Acute Cellular Rejection Predominated by Monocytes Is a Severe Form of Rejection in Human Renal Recipients With or Without Campath-1H (Alemtuzumab) Induction Therapy

This publication has 11 references indexed in Scilit:

• RESULTS FROM A HUMAN RENAL ALLOGRAFT TOLERANCE TRIAL EVALUATING THE HUMANIZED CD52-SPECIFIC MONOCLONAL ANTIBODY ALEMTUZUMAB (CAMPATH-1H)
  Transplantation, 2003
• Monocytes and peritubular capillary C4d deposition in acute renal allograft rejection11.See Editorial by Colvin, p. 1953.
  Kidney International, 2003
• The Banff 97 working classification of renal allograft pathology
  Kidney International, 1999
• Prope tolerance, perioperative campath 1H, and low-dose cyclosporin monotherapy in renal allograft recipients
  The Lancet, 1998
• Inhaled nitric oxide and heparin for infantile primary pulmonary hypertension
  The Lancet, 1998
• MONOCYTES-MACROPHAGES AND CYTOKINES/CHEMOKINES IN FINE-NEEDLE ASPIRATION BIOPSY CULTURES
  Transplantation, 1997
• INTERSTITIAL REJECTION, VASCULAR REJECTION, AND DIFFUSE THROMBOSIS OF RENAL ALLOGRAFTS
  Transplantation, 1996
• THE EXTENT OF PERITUBULAR CD14 STAINING IN RENAL ALLOGRAFTS AS AN INDEPENDENT IMMUNOHISTOLOGICAL MARKER FOR ACUTE REJECTION
  Transplantation, 1994
• Immunopathology of renal allograft rejection analyzed with monoclonal antibodies to mononuclear cell markers
  Kidney International, 1986
• Composition and in vitro cytotoxicity of cellular infiltrates in rejecting human kidney allografts
  Cellular Immunology, 1978